Drug Shortage Report for AA-LANSOPRAZOLE-AMOXICILLIN-CLARITHROMYCIN

Last updated on 2021-06-21 History
Report ID 125395
Drug Identification Number 02470780
Brand name APO-LANSOPRAZOLE-AMOXICILLIN-CLARITHROMYCIN
Common or Proper name APO-TRI-PACK HP
Company Name AA PHARMA INC
Market Status MARKETED
Active Ingredient(s) LANSOPRAZOLE AMOXICILLIN CLARITHROMYCIN
Strength(s) 30MG 500MG 500MG
Dosage form(s) CAPSULE (DELAYED RELEASE) KIT CAPSULE TABLET
Route of administration ORAL ORAL
Packaging size 56 BLS
ATC code A02BD
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2020-11-30
Actual start date 2020-12-01
Estimated end date 2021-07-16
Actual end date 2021-06-18
Shortage status Resolved
Updated date 2021-06-21
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1165 CREDITSTONE ROAD
VAUGHAN, ONTARIO
CANADA L4K 4N7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2021-06-21 French Compare
v13 2021-06-21 English Compare
v12 2021-06-15 French Compare
v11 2021-06-15 English Compare
v10 2021-04-16 French Compare
v9 2021-04-16 English Compare
v8 2021-03-08 French Compare
v7 2021-03-08 English Compare
v6 2021-03-08 French Compare
v5 2021-03-08 English Compare
v4 2020-12-01 English Compare
v3 2020-10-01 French Compare
v2 2020-10-01 English Compare
v1 2020-10-01 English Compare

Showing 1 to 14 of 14